GlaxoSmithKline Pharmaceuticals Limited announced the appointment of Bhushan Akshikar as Managing Director of the company, with effect from December 1, 2022. He succeeds Sridhar Venkatesh, who is moving to a senior role within GSK Group. According to the company’s exchange filing, “The Board of Directors of the Company at its meeting held today, has appointed…
GlaxoSmithKline Pharmaceuticals Limited announced the re-appointment of Sridhar Venkatesh as Managing Director of the company for a period of one year from 1st April 2022 to 31st March 2023. Sridhar Venkatesh is a senior business leader with more than 28 years of diverse experience in pharmaceuticals and healthcare. He joined GSK in 2011 as Head…
GlaxoSmithKline Pharmaceuticals Limited announced its decision to transfer its rights in relation to the Iodex and Ostocalcium brands to GlaxoSmithKline Asia Private Limited, subject to shareholder approval, for an aggregate consideration of Rs 1649 crores. The company also declared its financial results for the quarter ended June 30, 2021. Revenue for the quarter came in…
Sridhar Venkatesh has been appointed as Managing Director & VP of GSK India, effective 1 April 2020. He succeeds Annaswamy Vaidheesh who will retire from the Company effective 31 March 2020. Venkatesh is a senior business leader with more than 24 years of diverse experience in pharmaceuticals & healthcare and has a strong track record…